These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 22108588

  • 1. A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation.
    Pelz S, Stock P, Brückner S, Christ B.
    Exp Cell Res; 2012 Feb 01; 318(3):276-87. PubMed ID: 22108588
    [Abstract] [Full Text] [Related]

  • 2. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul 01; 287(1):G264-73. PubMed ID: 15044174
    [Abstract] [Full Text] [Related]

  • 3. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW, Sahai A, Malladi P, Whitington PF, Green RM.
    J Hepatol; 2004 Oct 01; 41(4):592-8. PubMed ID: 15464239
    [Abstract] [Full Text] [Related]

  • 4. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
    Kirsch R, Clarkson V, Verdonk RC, Marais AD, Shephard EG, Ryffel B, de la M Hall P.
    J Gastroenterol Hepatol; 2006 Jan 01; 21(1 Pt 1):174-82. PubMed ID: 16706830
    [Abstract] [Full Text] [Related]

  • 5. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, Williams J, dela Pena A, Francisco R, Osvath SR, Brooling J, Teoh N, Sedger LM.
    J Gastroenterol Hepatol; 2009 Mar 01; 24(3):443-52. PubMed ID: 19226377
    [Abstract] [Full Text] [Related]

  • 6. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis.
    Yamazaki Y, Kakizaki S, Horiguchi N, Sohara N, Sato K, Takagi H, Mori M, Negishi M.
    Gut; 2007 Apr 01; 56(4):565-74. PubMed ID: 16950832
    [Abstract] [Full Text] [Related]

  • 7. Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model.
    Winkler S, Borkham-Kamphorst E, Stock P, Brückner S, Dollinger M, Weiskirchen R, Christ B.
    Exp Cell Res; 2014 Aug 15; 326(2):230-9. PubMed ID: 24786317
    [Abstract] [Full Text] [Related]

  • 8. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM.
    Hepatology; 2009 Nov 15; 50(5):1421-30. PubMed ID: 19676126
    [Abstract] [Full Text] [Related]

  • 9. Interstrain differences in susceptibility to non-alcoholic steatohepatitis.
    Yamazaki Y, Kakizaki S, Takizawa D, Ichikawa T, Sato K, Takagi H, Mori M.
    J Gastroenterol Hepatol; 2008 Feb 15; 23(2):276-82. PubMed ID: 17868334
    [Abstract] [Full Text] [Related]

  • 10. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
    Salamone F, Galvano F, Cappello F, Mangiameli A, Barbagallo I, Li Volti G.
    Transl Res; 2012 Jun 15; 159(6):477-86. PubMed ID: 22633099
    [Abstract] [Full Text] [Related]

  • 11. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis.
    dela Peña A, Leclercq IA, Williams J, Farrell GC.
    J Hepatol; 2007 Feb 15; 46(2):304-13. PubMed ID: 17157947
    [Abstract] [Full Text] [Related]

  • 12. The pro-inflammatory action of tumour necrosis factor-α in non-alcoholic steatohepatitis is independent of the NSMAF gene product.
    Mas E, Danjoux M, Garcia V, Carpentier S, Ségui B, Levade T.
    Dig Liver Dis; 2013 Feb 15; 45(2):147-54. PubMed ID: 23044079
    [Abstract] [Full Text] [Related]

  • 13. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
    Locatelli I, Sutti S, Vacchiano M, Bozzola C, Albano E.
    Clin Sci (Lond); 2013 Feb 15; 124(4):279-87. PubMed ID: 22970906
    [Abstract] [Full Text] [Related]

  • 14. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A, Dahm F, Jochum W, Jang JH, Georgiev P, Bader M, Renner EL, Clavien PA.
    Gastroenterology; 2007 Aug 15; 133(2):608-18. PubMed ID: 17681180
    [Abstract] [Full Text] [Related]

  • 15. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
    Simon Y, Kessler SM, Gemperlein K, Bohle RM, Müller R, Haybaeck J, Kiemer AK.
    World J Gastroenterol; 2014 Dec 21; 20(47):17839-50. PubMed ID: 25548482
    [Abstract] [Full Text] [Related]

  • 16. Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats.
    Luo ZL, Tang LJ, Wang T, Dai RW, Ren JD, Cheng L, Xiang K, Tian FZ.
    J Gastroenterol Hepatol; 2014 Jan 21; 29(1):215-22. PubMed ID: 24117897
    [Abstract] [Full Text] [Related]

  • 17. Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis.
    Rangnekar AS, Lammert F, Igolnikov A, Green RM.
    Liver Int; 2006 Oct 21; 26(8):1000-5. PubMed ID: 16953841
    [Abstract] [Full Text] [Related]

  • 18. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats.
    Nakano T, Cheng YF, Lai CY, Hsu LW, Chang YC, Deng JY, Huang YZ, Honda H, Chen KD, Wang CC, Chiu KW, Jawan B, Eng HL, Goto S, Chen CL.
    J Hepatol; 2011 Aug 21; 55(2):415-25. PubMed ID: 21184788
    [Abstract] [Full Text] [Related]

  • 19. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
    McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC.
    Hepatology; 2004 Aug 21; 40(2):386-93. PubMed ID: 15368443
    [Abstract] [Full Text] [Related]

  • 20. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
    Zhang S, Wang J, Liu Q, Harnish DC.
    J Hepatol; 2009 Aug 21; 51(2):380-8. PubMed ID: 19501927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.